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Objectives: Oral leukoplakia (OL) is the main potentially malignant disorder and oral squamous cell carcinoma 
(OSCC) is the most common malignancy of the oral mucosa. Stromal myofibroblasts play an important role in 
tumor invasion and metastasis, due to its ability to modify the extracellular matrix. This study aimed to evaluate 
the presence of stromal myofibroblasts in OL and OSCC. Differences in the presence of myofibroblasts among OL 
with distinct grades of epithelial dysplasia as well as between histologically high- and low-invasive OSCC were 
also assessed. 
Study Design: A total of 30 OL and 41 OSCC from archival formalin-fixed, paraffin-embedded specimens were 
evaluated. 10 samples of normal oral mucosa were used as a control. Myofibroblasts were identified by immuno-
histochemical detection of alpha smooth muscle actin and its presence was classified as negative, scanty or abun-
dant. Differences in the presence of myofibroblasts among OL with distinct grades of epithelial dysplasia as well 
as between high- and low-invasive OSCC were analyzed using the Mann-Whitney test.
Results: Myofibroblasts were not detected in normal oral mucosa and OL, whatever its histological grade. In 
OSCC, the presence of stromal myofibroblasts was classified as negative in 11 (26.8%), scanty in 15 (36.6%), and 
abundant in 15 samples (36.6%). The presence of stromal myofibroblasts was statistically higher in high-invasive 
OSCC than in low-invasive OSCC (p<0.05). 
Conclusions: Stromal myofibroblasts were not detected in OL, indicating that these cells are not important dur-
ing oral carcinogenesis. Nevertheless, stromal myofibroblasts were heterogeneously detected in OSCC and its 
presence was higher in tumors with a more diffuse histological pattern of invasion. These findings suggest that 
myofibroblasts are associated with the creation of a permissive environment for tumor invasion in OSCC.
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Introduction 
Leukoplakia is the most common potentially malignant 
disorder of the oral mucosa, recently redefined as a whi-
te plaque of questionable risk having excluded other 
known diseases or disorders that carry no increased risk 
for cancer (1). Oral leukoplakia (OL) mainly affects men 
over 40 years old and tobacco use is its most important 
pre-disposing factor (2). OL is histologically categori-
zed in rising grades of epithelial dysplasia and its rate of 
malignant transformation ranges among 0.13% to 2.2% 
per year (2).
Oral squamous cell carcinoma (OSCC) is one of the 
most common malignances worldwide (3). OSCC 
mainly affects men over 40 years old (4) and the most 
relevant risk factors for its development are tobacco and 
alcohol (5). The tumor may arise in any site of the oral 
cavity chiefly in lower lip, tongue, floor of mouth, soft 
palate, and gingival/alveolar ridge (4). 
Myofibroblasts are differentiated fibroblasts that express 
alpha smooth muscle actin and have intermediate cha-
racteristics between classic fibroblasts and smooth mus-
cle cells (6-8). Its most referred origin is the fibroblast 
transdifferentiation stimulated by cytokines as TGF-β1 
(6). Due to its ability to modify the extracellular matrix, 
myofibroblasts play an important role in tumor invasion 
and metastasis (9,10). The presence of stromal myofi-
broblasts has been associated with a worse prognosis 
in epithelial malignant tumors (11,12) including OSCC 
(13,14). 
The aim of this study was to evaluate the presence of 
stromal myofibroblasts in OL and OSCC. Differences in 
the presence of stromal myofibroblasts among OL with 
distinct grades of epithelial dysplasia as well as between 




This study was approved by the local ethics committee. 
A total of 30 OL and 41 OSCC from archival formalin-
fixed, paraffin-embedded specimens were evaluated. 10 
samples of normal oral mucosa were used as a control.
Of the 30 patients whose OL were evaluated, 17 were 
men and 13 were women, ranging from 33 to 81 years of 
age (mean age, 52 years). In OSCC samples, 30 patients 
were men and 11 were women, ranging from 27 to 81 
years of age (mean age, 59 years). 
Histological grading of OL
The histological grading of OL was performed on he-
matoxylin and eosin stained sections, as described el-
sewhere (15).  
Of the 30 OL samples, 13 were classified as OL showing 
no or mild epithelial dysplasia and 17 were classified as 
OL showing moderate or severe epithelial dysplasia.
Evaluation of the pattern of invasion of OSCC
The pattern of invasion of OSSC samples was perfor-
med on hematoxylin and eosin stained sections, accor-
ding to Bryne et al. (16). The pattern of invasion was 
classified as: grade 1 - pushing, well delineated infiltra-
ting borders; grade 2 - infiltrating, solid cords, bands 
and/or strands; grade 3 - small groups or cords of infil-
trating cells (n >15); grade 4 - marked and widespread 
cellular dissociation in small groups and/or in single 
cells (n <15). 
Of the 41 OSCC samples, 16 were classified as low-
invasive OSCC (pattern of invasion grade 1 or 2) and 
25 were classified as high-invasive OSCC (pattern of 
invasion grade 3 or 4).
Immunohistochemistry
Myofibroblasts were identified by immunohistochemi-
cal detection of alpha smooth muscle actin. Four µm 
sections from the paraffin-embedded samples were 
used. Tissue sections were dewaxed with xylene, hydra-
ted using graded alcohols, and treated with 0.6% H2O2 
to eliminate endogenous peroxidase activity. Antigen 
retrieval was conducted by heating in a 0.01 M citra-
te buffer (pH 6.0) for 30 minutes. Subsequently, the 
anti - alpha smooth muscle actin monoclonal antibody 
was used (clone 1A4, diluted 1:100; Dako Corporation, 
Carpinteria, USA). The LSAB+ kit (Dako Corporation, 
Carpinteria, USA) was used for application of the bio-
tinylated link antibody and peroxidase-labeled strep-
tavidin, according to the manufacturer’s instructions. 
The reactive products were visualized by immersing 
the sections for 3 min in 0.03% diaminobenzidine so-
lution, containing 2 mM H2O2. The sections were then 
counterstained with Mayer’s hematoxylin, dehydrated, 
and mounted. Normal vessel’s smooth muscle immuno-
reactivity was used as internal positive control.  Nega-
tive control was determined by omission of the primary 
antibody. 
Scoring of immunostaining results
A light microscopy was used to evaluate the immuno-
histochemical reactions. Alpha smooth muscle actin po-
sitive stromal cells, showing cytoplasmatic immunostai-
ning, were considered as myofibroblasts. The presence 
of stromal myofibroblasts was assessed independently 
by two authors (HMA and MCRH) and qualitatively 
classified as negative, scanty or abundant, as described 
elsewhere (13).  Doubtful cases were reanalyzed and a 
consensus score agreed. Samples in which no stromal 
myofibroblasts were detected were classified as nega-
tive. Samples showing sporadic stromal myofibroblasts 
were classified as scanty. Samples showing numerous 
and densely arranged stromal myofibroblasts were clas-
sified as abundant. 
Statistical analysis
The data were analyzed by means of BioEstat 5.0 soft-
ware (Optical Digital Technology, Belém, Brazil). Di-
fferences in the presence of myofibroblasts among OL 
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with distinct grades of epithelial dysplasia as well as 
between high- and low-invasive OSCC were analyzed 
using the Mann-Whitney test. The level of significance 
was established at 5%.
Results
Stromal myofibroblasts were not observed in normal 
oral mucosa used as a control (Table 1). 
Stromal myofibroblasts were also not detected in any of 
the 30 OL samples, whatever its histological grade (Fig. 
1A and B) (Table 1). 
ogy, palely eosinophilic cytoplasm, and an abundant 
pericellular matrix), immunophenotype characteristics 
(positivity for markers as alpha smooth muscle actin), 
and ultrastructure features (prominent rough endoplas-
matic reticulum, a Golgi apparatus producing collagen 
secretion granules, peripheral myofilaments, fibronexus 
junctions and gap junctions) (8). Myofibroblasts synthe-
size and secrete cytokines, growth factors, inflamma-
tory mediators, extracellular matrix proteins, metallo-
proteinases, and tissue inhibitors of metalloproteinases. 
Therefore, play an important role during embryogen-
Samples             Presence of myofibroblasts P-value 1 
Negative Scanty Abundant 
Normal oral mucosa (n=10) 10 (100%) 0 0  
OL (n=30) 30 (100%) 0 0  
Low-invasive OSCC a (n=16) 9 (56.25%) 4 (25%) 3 (18.75%) 
<0.05* 
High-invasive OSCC b (n=25) 2 (8%) 11 (44%) 12 (48%) 
 
Table 1. Presence of stromal myofibroblasts in normal oral mucosa, oral leukoplakia (OL) and oral 
squamous cell carcinoma (OSCC).  
1 P-value was obtained through the Mann-Whitney test
* Low-invasive OSCC versus High-invasive OSCC
a Low-invasive OSCC: Tumors showing pattern of invasion grade 1 (pushing, well delineated infiltrating 
borders) or grade 2 (infiltrating, solid cords, bands and/or strands)
b High-invasive OSCC: Tumors showing pattern of invasion grade 3 (small groups or cords of infiltrating 
cells) or grade 4 (marked and widespread cellular dissociation in small groups and/or in single cells)
In the 41 samples of OSCC, the presence of stromal 
myofibroblasts was classified as negative in 11 (26.8%) 
(Fig. 1C and D), scanty in 15 (36.6%) (Fig. 1E and F) and 
abundant in 15 (36.6%) (Fig. 1G and H).  
Once OSCC samples were separated in low-invasive and 
high-invasive tumors, a remarkable difference in the 
presence of stromal myofibroblasts was observed (Table 
1). In 16 samples of low-invasive OSCC, the presence of 
myofibroblasts was classified as negative in 9 (56.25%), 
scanty in 4 (25%) and abundant in 3 (18.75%).  In 25 
samples of high-invasive OSCC, the presence of myo-
fibroblasts was classified as negative in 2 (8%), scanty 
in 11 (44%) and abundant in 12 (48%). Consequently, 
the presence of stromal myofibroblasts was statistical-
ly higher in high-invasive OSCC than in low-invasive 
OSCC (p<0.05).
Discussion
The term myofibroblast was introduced in the early 
1970s to name fibroblasts that, under certain condi-
tions as granulation tissue contraction, are capable of 
modulating toward a cell type structurally and func-
tionally close to smooth muscle (6). A comprehensive 
recent definition of the myofibroblast includes light mi-
croscopy features (spindle-cell or stellate-cell morphol-
esis, organogenesis, inflammation, would healing and 
cancer (6-10).
Due to its ability to modify the extracellular matrix, 
myofibroblasts actively participate in tumor invasion 
and metastasis (9,10). Metastasis is a complex process 
that depends on many interactions among tumor cells 
and the microenvironment, involving a sequence of 
events characterized by tumor growth and angiogene-
sis, detachment between the tumor cells, invasion of the 
extracellular matrix (ECM), vascular dissemination, 
extravasation in target organs, and establishment of 
secondary tumor. During the ECM invasion, the tumor 
cell must adhere to its components, promote its degra-
dation by metalloproteinases, and then move through 
the degraded ECM (17,18). This dynamic process of 
ECM remodeling, called stromagenesis, is orchestrated 
by stromal myofibroblasts and creates a permissive envi-
ronment for tumor growth, invasion and metastasis (10). 
Myofibroblasts were not observed in any of the 30 OL 
samples evaluated, no matter what the OL histological 
grade (Table 1). Similar results from prior literature have 
been observed as regards OL (13,19) and dysplastic epi-
thelium in rat tongue carcinogenesis model (20). These 
results suggest that myofibroblasts are not present in the 
stroma during oral carcinogenesis, even in its advan-
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Fig. 1. Immunohistochemical reactivity for alpha smooth muscle actin in oral leukoplakia (OL) and oral squamous cell 
carcinoma (OSCC). Alpha smooth muscle actin positive stromal cells, showing cytoplasmatic immunostaining, were con-
sidered as myofibroblasts. Normal vessel’s smooth muscle immunoreactivity was used as internal positive control. Myo-
fibroblasts were not observed in OL [original magnification: x100(A) and x200(B)]. In OSCC, the presence of myofibro-
blasts was negative [original magnification: x100(C) and x200(D)], scanty [original magnification: x100(E) and x200(F)] 
or abundant [original magnification: x100(G) and x200(H)]. 
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ced stages. These results also reinforce the hypothesis 
that, in this process, the appearance of myofibroblasts is 
entirely dependent on the OSCC development (20) and 
contact among OSCC cells and the stroma is needed to 
induce myofibroblast transdifferentiation (13). Never-
theless, myofibroblasts were in fact associated with the 
increasing grade of epithelial dysplasia in other anato-
mic sites, as the uterine cervix (21). 
Our results showed the presence of myofibroblasts 
(scanty or abundant) in 73.2% of the OSCC samples. 
These findings are in accordance with previous reports 
evaluating OSCC (13,14,22-25). These results suggest 
that stromal remodeling induced by OSCC is characte-
rized by gain of myofibroblasts, as originally reported 
by Barth et al. (22) and Lewis et al. (23). The myofibro-
blast is a key cell in the stromatogenesis, a dynamic pro-
cess in ECM remodeling, induced by tumor cells, that 
creates a permissive environment for tumor growth, lo-
cal invasion and metastasis (10). Kellermann et al. (13) 
demonstrated that OSCC showing abundant presence 
of myofibroblasts are associated to higher proliferative 
activity of tumor cells, regional metastasis and survival, 
in relation to OSCC with negative and scanty myofibro-
blasts. Moreover, Marsh et al. (14) have recently de-
monstrated that the presence of stromal myofibroblasts 
is an effective predictor of OSCC mortality and is as-
sociated to a group of patients with aggressive tumors, 
regardless of tumor stage.
The presence of myofibroblasts was negative in 26.8%, 
scanty in 36.6%, and abundant in 36.6% of the OSCC 
samples. This heterogeneous presence of stromal 
myofibroblasts in OSCC has been previous reported 
(13,14,22-25). Since TGF-β1 secretion by OSCC cell li-
nes induce oral fibroblast transdifferentiation into myo-
fibroblasts (23, 26), this heterogeneity should be explai-
ned by disparity in TGF-β1 expression among different 
OSCC samples (27). The role of TGF-β1 in neoplasia is 
complex, switching from tumor supressor in the prema-
lignant phases of carcinogenesis to prooncogene at la-
ter stages of cancer, enhancing invasion and metastasis 
through epigenetic mechanisms (28). 
Once OSCC samples were separated in low-invasive 
and high-invasive tumors, a remarkable difference in 
the presence of stromal myofibroblasts was observed 
(Table 1). The presence of stromal myofibroblasts was 
statistically higher in high-invasive OSCC than in low-
invasive OSCC (p<0.05). The pattern of invasion is an 
important histological parameter that reflects the inva-
sive features of the tumor (16) and OSCC with more 
diffuse pattern of invasion presents a worse prognosis 
(29). Furthermore, it has been reported that OSCC that 
invaded in small groups or with widespread cellular 
dissociation (high-invasive tumors; pattern of invasion 
grades 3 or 4) showed a higher tendency to metastasize 
to regional lymph nodes when compared with OSCC 
that invaded in well delineated borders or in solid cords, 
bands and/or strands (low-invasive tumors; pattern of 
invasion grades 1 or 2) (30). Therefore, our findings 
reinforce the statement that the presence of myofibro-
blasts in the stroma of OSCC creates a permissive envi-
ronment for tumor invasion and metastasis.
In conclusion, stromal myofibroblasts were not detected 
in OL, indicating that these cells are not significant dur-
ing oral carcinogenesis. Nevertheless, stromal myofi-
broblasts were heterogeneously detected in OSCC and 
its presence was higher in tumors with a more diffuse 
histological pattern of invasion. These findings suggest 
that myofibroblasts are associated with the creation of 
a permissive environment for tumor invasion in OSCC 
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